|
GBR 2015
COI 3.34 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
-
12/10/2022
Degenerative myelopathy (DM)
N/N (clear)
-
12/10/2022
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
12/10/2022
Hips
Mild / C2 / 13-18 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
12/10/2022
|
GBR 2010
COI 0.60 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
|||
|
GBR 2004
COI 2.09 %
*
Breed relevant health information:
Elbows
normal
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
||
FIN 2005
COI 3.52 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
21/9/2006
|
|||
GBR 2017
COI 2.29 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2013
COI 0.46 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
-
29/7/2014
|
FIN 2009
COI 2.75 %
*
Breed relevant health information:
Hips
Mild / C1 / 9-12 / C / 26-35
-
12/6/2013
Year of death:
2015
Cause of death:
Unspecified/Other Endocrine System Disease
|
|
FIN 2011
COI 4.94 %
*
Breed relevant health information:
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
4/12/2012
|
|||
|
|
||
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Arianrhod Finntroll
|
24 Aug 2015 | N/N (clear) | N/N (clear) | N/N (clear) | Mild / C2 / 13-18 / C / 26-35 | N/N (clear) | ||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Mild / C2 / 13-18 / C / 26-35
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Glenchess Kiuru over Pavoskas
|
10 Apr 2017 | N/N (clear) | N/N (clear) | Borderline / B2 / 7-8 / B / 19-25 | N/N (clear) | |||||
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Borderline / B2 / 7-8 / B / 19-25
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Pavoskas Galaksiitti
|
25 Aug 2022 | |||||||||
Pavoskas Galena
|
25 Aug 2022 | |||||||||
Pavoskas Granaatti
|
25 Aug 2022 | |||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Pavoskas Fennel
|
16 May 2021 | |||||||||
Pavoskas Flora
|
16 May 2021 | |||||||||
Pavoskas Forest JW
|
16 May 2021 | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | ||||||||
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
|
||||||||||
Pavoskas Foxglove
|
16 May 2021 | |||||||||
Pavoskas Fuchsia
|
16 May 2021 | |||||||||
Offspring |